According to fund manager, it is time to invest in companies with “defensive growth”
Investors should be “more defensive” in their portfolios right now, in part because of high market prices, said portfolio manager Brian Arcese. Stocks are still expensive despite market volatility and declines in recent weeks, said Arcese, who works at Foord…
Eli Lilly’s outstanding quarter should calm concerns about the stock
Eli Lilly on Thursday reported a successful quarter driven by sales of its blockbuster obesity and diabetes drugs, allaying any lingering investor concerns about the stock. Second-quarter revenue rose 36% year-over-year to $11.3 billion, beating expectations of $9.92 billion, according…
